A phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in recurrent malignant brain tumors.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples